Analysts Offer Insights on Healthcare Companies: Teleflex Inc (NYSE: TFX) and Epizyme (NASDAQ: EPZM)

By Ryan Adsit

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Teleflex Inc (NYSE: TFX) and Epizyme (NASDAQ: EPZM) with bullish sentiments.

Teleflex Inc (NYSE: TFX)

Barclays analyst Matthew Taylor maintained a Buy rating on Teleflex Inc (NYSE: TFX) on June 23 and set a price target of $225. The company’s shares closed on Friday at $206.11, close to its 52-week high of $211.22.

According to TipRanks.com, Taylor is a 5-star analyst with an average return of 10.9% and a 71.7% success rate. Taylor covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Baxter International.

Teleflex Inc has an analyst consensus of Strong Buy, with a price target consensus of $227.25.

Epizyme (NASDAQ: EPZM)

Oppenheimer analyst Leah R. Cann reiterated a Buy rating on Epizyme (NASDAQ: EPZM) today and set a price target of $26. The company’s shares closed on Friday at $14.70.

R. Cann observed:

“Epizyme, Inc. announced today that it has expanded its clinical collaboration with Genentech, a member of the Roche Group. Under the new agreement, Tazemetostat administered in combination with atezolizumab (Tecentriq) will be evaluated in a phase Ib/II clinical study for the treatment of patients with relapsed/refractory metastatic non-small cell lung cancer (NSCLC).”

According to TipRanks.com, Cann is a 4-star analyst with an average return of 12.5% and a 84.3% success rate. Cann covers the Healthcare sector, focusing on stocks such as CytomX Therapeutics Inc, Syros Pharmaceuticals, and Seattle Genetics.

Currently, the analyst consensus on Epizyme is Strong Buy and the average price target is $24.20, representing a 64.6% upside.

In a report issued on June 12, RBC Capital also reiterated a Buy rating on the stock with a $20 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.